Professional Documents
Culture Documents
Objectives
Side effects
Drug interactions
Monitoring
2
References
Outline
Endpoints
Available agents & indications
Individual agents
Important treatment issues
Status Epilepticus
4
Definition
seizure vs epilepsy
Sx
clinical menifestation
Definition
Epilepsy
Convulsion
disease
"FIT"
Outline
Endpoints
Available agents & indications
Individual agents
Important treatment issues
Status Epilepticus
8
Classification
of seizure
type
First attack:
stimulant ? Treat or not?
Laboratory/
Consider EEG
Electroencephalog
evidence &
ram (EEG) / CT/
individual
MRI
factors
description
medical Hx
EEG
Recurrent:
Drug treatment
Classification
Generalized Seizures
calm
side lay
10
remove danger
observe record Sx
Generalized Seizures
ABSENCE
11
Generalized Seizures
MYOCLONIC
ATONIC
12
Classification
Partial Seizures
SIMPLE PARTIAL
13
Classification
Partial Seizures (cont.)
COMPLEX PARTIAL
14
Classification
one side, spread to both side
Tx as partial as started as partial
15
Outline
Endpoints
Available agents & indications
Individual agents
Important treatment issues
Status Epilepticus
16
Treatment
predisposing factor?
Non-pharmacological
Response to AED
Seizure frequency 5/mo --> 2/mo = improve, but not at goal (0)
Presence & severity of dose-related toxicity
19
Therapeutic endpoints
Choice of drugs
Type of seizure
Side effect profile
Drug interactions
Previous drug experience
20
Add-on +
Monotherapy
Established
New
Phenobarbital
Phenytoin
Carbamazepine 1st line
Valproate
Lamotrigine
Gabapentin
Oxcarbazepine
Topiramate
Levetiracetam
Pregabalin
Lacosamide (Vimpat)
Retigabine (Trobalt)
Add-on only
Clobazam
Clonazepam
Vigabatrin
Tiagabine*
Zonisamide*
Treatment options
Partial
GTC
Absence
Atonic/
myoclonic
Carbamazepine
Clobazam
3 (m)
Clonazepam
1-2
4 (m)
Lorazepam
Ethosuximide
Gabapentin
unique
2
Pregabalin
Lacosamide
Lamotrigine
Levetiracetam
3 (m)
Oxcarbazepine
Phenytoin
3 (m)
1 only
4 (m)
LennoxGastaut
syndrome
1 typo
XX
Retigabine
Valproate acid
Topiramate
Status
Epilepticus
Diazepam
Infantile
Spasms
1
3
1
1
1- 1st line
2- 2nd line
3- some effect
4- adjunctive
22
fail Na blocking
use Ca blocking
Lason W et al.
Pharmacological Reports
2011; 63:271-92
23
gene test
SIADH
neutropenia
Carbamazepine
inducer
Dosage and Administration
Blood levels
24
Case Study 1
Hypertension
Depression
Adalat retard
Sertraline 100mg PO QD
Carbamazepine 200mg PO BD
25
Case Study 1
26
Case Study 1
Oxcarbazepine (Trileptal)
better tolerated, less DDI
still SIADH
May ______________________________________________
reduce the potency of oral contraceptives
Phenytoin
Phenytoin
ADR
GI upset (common)
Sedation
qHS
Cardiac side effects (sinus bradycardia, shortened
PR intervals)(rare)
Gingival hyperplasia cosmetic concern common, dose dependent
Phenytoin
31
Phenytoin
Toxicity
Nystagmus
Management
Drug discontinuation
Supportive care if needed
32
Phenytoin
Dosing & administration
Irritating
Avoid IM & IV in small veins
Poor solubility in water & at neutral pH
use NS
Requires slow infusion in glucose free solutions to avoid precipitation
Fosphenytoin: water-soluble prodrug of phenytoin not in HK
useful IM inj > iV infusion
Oral loading dose:
fast cure
33
Therapeutic range:
34
Ethosuximide
35
Ethosuximide
GISE
36
Lamotrigine
37
Newer treatments
Gabapentin (Neurontin)
Vigabatrin (Sabril) visual view
Levetiracetam (Keppra)
Topiramate (Topamax)
Pregabalin (Lyrica)
Lacosamide (Vimpat)
Retigabine (Trobalt)
38
Newer treatments
39
Elimination
Side effects
Behavioral changes, Wt gain
Behavioral changes; maybe
some psychosis & hallucination.
Somnolence & weakness
Hyponatremia, rash, nausea
most renal
Drug
interactions
-
Gabapentin
Levetiracetam
6
7
Renal 100%
Renal 60%,
hydrolysis 34%
Oxcarbazepine
2 (active
metabolite
12.5)
6
Hepatic 70%
Renal mostly
19
Renal 55%
Vigabatrin
5-7
Renal
Lacosamide
13 (active
metabolite 1523)
6-10
Renal mostly;
2C19 substrate
Language impairment, ?
Cognitive impairment, weight loss,
kidney stones, metabolic acidosis
Amnesia; blurred vision; blueyellow color blindness; vision or
other vision changes; eye pain
>10%: dizziness, headache,
nausea, diplopia
>10%: dizziness, somnolence,
fatigue
Urinary retention in 5%
~9% reported confusion new
Pregabalin
Topiramate
Retigabine
Renal
+ (CBZ &
phenytoin)
-
Pharmacokinetic Interactions
Affects
Affected by
other AEDs
other AEDs
AED
Metabolism
Gabapentin
Not metabolised
Lamotrigine
Glucuronidation
Levetiracetam
Nonhepatic hydrolysis
Oxcarbazepine
Glucuronidation/CYP
Pregabalin
Not metabolised
Topiramate
CYP/glucuronidation
Vigabatrin
Not metabolised
Lacosamide
Not metabolised
Retigabine
Not metabolised
newer agent
41
Newer treatments
Drug interactions
Topiramate:
42
Outline
Endpoints
Available agents & indications
Individual agents
Important treatment issues
Status Epilepticus
43
Dosage
Clinical response
poor correlation
individual variation
most important
45
common
46
Lason W et al.
Pharmacological Reports
2011; 63:271-92
48
51
52
Risk ~ 6%
Folic acid
not confirm
55
Forced normalization
Folate deficiency
Enhanced GABA neurotransmission
History of affective disorders
56
Case Study 2
57
Case Study 2
58
Case Study 2
Diazepam
Lorazepam
Phenytoin
Valproate
59
Outline
Endpoints
Available agents & indications
Individual agents
Important treatment issues
Status Epilepticus
60
Status Epilepticus
Status Epilepticus
62
Treatment
Ensure ventilation
Position on side to prevent aspiration
Terminate current seizure activity
IV rapid-acting anticonvulsant
Lorazepam
2-4mg IV dose
Diazepam
5mg/min IV dose
63
Treatment (cont.)
64
Case study 3
PMH: depression
Current meds
in range
stress?
65
Case study 3
Case study 3
C.
D.
Case study 3
D.
Whats next?
68
The End
69